Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Share-based Compensation: 2016-2022

Historic Share-based Compensation for MediWound (MDWD) over the last 4 years, with Dec 2022 value amounting to $3.2 million.

  • MediWound's Share-based Compensation rose 9.95% to $3.2 million in Q4 2022 from the same period last year, while for Dec 2022 it was $1.9 million, marking a year-over-year increase of 16.32%. This contributed to the annual value of $3.1 million for FY2024, which is 61.75% up from last year.
  • Per MediWound's latest filing, its Share-based Compensation stood at $3.2 million for Q4 2022, which was up 559.69% from -$707,000 recorded in Q3 2022.
  • Over the past 5 years, MediWound's Share-based Compensation peaked at $3.2 million during Q4 2022, and registered a low of -$707,000 during Q3 2022.
  • Its 3-year average for Share-based Compensation is $411,750, with a median of -$345,500 in 2020.
  • As far as peak fluctuations go, MediWound's Share-based Compensation soared by 55.79% in 2018, and later crashed by 121.97% in 2021.
  • Over the past 5 years, MediWound's Share-based Compensation (Quarterly) stood at -$149,000 in 2018, then tumbled by 117.45% to $2.2 million in 2019, then increased by 3.70% to $2.2 million in 2020, then skyrocketed by 31.67% to $3.0 million in 2021, then grew by 9.95% to $3.2 million in 2022.
  • Its Share-based Compensation stands at $3.2 million for Q4 2022, versus -$707,000 for Q3 2022 and -$252,000 for Q2 2022.